Abbott Laboratories CDR (ABL0) - Financials, balance sheet (quarterly)

15.20000 EUR

0.4

2.70%

Last update Jul 2, 8:06 AM CEST

Market closed

Day range

15.20000

Previous close

14.80000

Open

15.20000

Access this stock data via API

Abbott Laboratories CDR

15.20

0.40

2.70%

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	81.4B	81.4B	74.4B	73.0B
Current assets	23.2B	23.7B	23.8B	23.1B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	6.5B	7.6B	7.6B	7.0B
Other short term investments	312M	351M	230M	232M
Accounts receivable	7.3B	6.9B	7.1B	6.9B
Other receivables	2.3B	2.6B	2.2B	2.2B
Inventory	6.6B	6.2B	6.8B	6.8B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	58.3B	57.8B	50.6B	49.9B
Properties	—	15.5B	—	—
Land and improvements	—	528M	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	2.5B	—	—
Leases	—	—	—	—
Accumulated depreciation	-12.5B	-12.1B	-12.2B	-11.8B
Goodwill	53.0B	52.9B	54.7B	54.4B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	6.3B	6.6B	7.4B	7.8B
Investments and advances	907M	886M	912M	877M
Other non current assets	16.8B	16.5B	8.0B	7.7B
Total liabilities	32.4B	33.5B	34.3B	33.5B
Current liabilities	13.0B	14.2B	14.9B	13.8B
Accounts payable	4.2B	4.2B	4.0B	4.1B
Accrued expenses	6.8B	6.2B	7.0B	6.5B
Short term debt	506M	1.5B	2.2B	1.6B
Deferred revenue	—	—	—	—
Tax payable	485M	594M	713M	601M
Pensions	—	—	—	—
Other current liabilities	—	—	—	—
Non current liabilities	19.4B	19.4B	19.4B	19.7B
Long term provisions	—	—	—	—
Long term debt	12.7B	13.5B	12.8B	13.1B
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	512M	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	6.6B	3.4B	6.6B	6.6B
Shareholders equity
Common stock	25.1B	25.2B	25.0B	24.9B
Retained earnings	47.7B	47.3B	39.1B	38.4B
Other shareholders equity	-7.4B	-7.9B	-7.8B	-8.1B
Total shareholders equity	49.1B	47.9B	40.0B	39.6B
Additional paid in capital	—	—	—	—
Treasury stock	16.6B	16.8B	16.5B	15.8B
Minority interest	253M	237M	232M	242M